Morgan Ebert, Managing Editor

A UK study links maternal anemia in early pregnancy with increased congenital heart disease risk in offspring.

New model refines prevalence estimates, reduces misdiagnoses compared to the current coding system.

A recent study found reduced preterm birth, complications, and NICU use in large Tennessee Medicaid cohort.

Study finds education from multiple sources increases parent inquiry about firearms.

New data from national survey highlights disparities and need for focused prevention strategies.

Early antibiotic use before age 2 is linked to higher childhood obesity risk, with timing playing a key role in long-term weight outcomes.

Most want to start the conversation, but confidence and timing vary.

Can you diagnose this patient? Take our poll and find out! Then check back for the full case, differential diagnosis, and correct diagnosis.

A recent study found IL-6 may help with earlier sepsis detection in pregnant women, children, and newborns, outperforming traditional diagnostic tests.

Two-thirds of US teen girls live in states with abortion bans, gestational limits, or parental involvement laws, limiting access to care.

CBD cannabis extract may improve social responsiveness and reduce disruptive behavior in children with autism, with no increase in adverse effects, according to a recent study

Primary care interventions, such as education and support, effectively promote breastfeeding up to 6 months, improving rates of any and exclusive breastfeeding, according to the USPSTF.

A new study published in JAMA Open Network suggests that early-life exposure to ambient ozone (O3) may contribute to an increased risk of asthma and wheeze in young children.

View our Q1 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.

Aquestive Therapeutics reports positive pediatric study results for Anaphylm, supporting its FDA submission for treating severe allergic reactions.

A look ahead to 5 key regulatory decisions scheduled to take place during the second quarter of 2025, from a monoclonal antibody to topical psoriasis treatments.

A new clinical trial has found that omalizumab (Xolair; Genetech, Novartis) is more effective than oral immunotherapy (OIT) in treating multi-food allergy in individuals with severe allergic reactions to small amounts of common food allergens.

A nurse-led intervention increased HPV vaccination rates among Hispanic adolescents in a rural North Carolina clinic, according to research presented at the 2025 NAPNAP conference.

Early anxiety screening in pediatric primary care improves detection, outcomes, and access to mental health support starting at age 8.

If approved, SYD-101 would be the first and only pharmaceutical option for the treatment of progression of pediatric myopia in the United States.

The study, known as BRAVE-AA-PEDS, was sponsored by Eli Lilly and Company and involved 257 adolescents aged 12 to under 18 years.

The newest tapinarof results were presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting.

Lebrikizumab improves itch, sleep interference, and skin pain in atopic dermatitis patients previously treated with dupilumab, offering a new treatment option.

Cytomegalovirus (CMV) may worsen necrotizing enterocolitis (NEC) in premature infants, leading to severe intestinal damage.

Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] has now launched in the US for children aged 1 through 3 years with a confirmed diagnosis of peanut allergy.

A study finds air lead exposure increases infant mortality, linking emissions to low birthweight, SUID, and respiratory issues, urging stricter regulations.

The FDA has accepted PTC Therapeutics' NDA for vatiquinone, a potential treatment for Friedreich's ataxia, with a decision expected by August 19, 2025.

A study found that teens with obesity eat more later in the day than their peers, highlighting the role of the body’s circadian system in eating habits.

Most children with MIS-C recover within 6 months, with heart function and overall health improving significantly, according to a new study.